15. Inclusion body myositis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 42 / Drugs : 33 - (DrugBank : 11) / Drug target genes : 12 - Drug target pathways : 123
Inclusion body myositis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 15 | Inclusion body myositis | - |
| 46 | Malignant rheumatoid arthritis | 5.913 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 5.884 |
| 86 | Pulmonary arterial hypertension | 3.436 |
| 49 | Systemic lupus erythematosus | 3.416 |
| 97 | Ulcerative colitis | 3.387 |
| 2 | Amyotrophic lateral sclerosis | 3.368 |
| 56 | Behcet disease | 2.652 |
| 84 | Sarcoidosis | 2.439 |
| 65 | Primary immunodeficiency | 2.424 |
| 96 | Crohn disease | 2.354 |
| 94 | Primary sclerosing cholangitis | 1.990 |
| 50 | Dermatomyositis | 1.667 |
| 107 | Juvenile idiopathic arthritis | 1.650 |
| 298 | Hereditary pancreatitis | 1.647 |
| 222 | Primary nephrotic syndrome | 1.621 |
| 28 | Systemic amyloidosis | 1.609 |
| 19 | Lysosomal storage disease | 1.602 |
| 299 | Cystic fibrosis | 1.561 |
| 51 | Scleroderma | 1.545 |
| 6 | Parkinson disease | 1.509 |
| 280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 1.286 |
| 106 | Cryopyrin-associated periodic syndrome | 1.182 |
| 37 | Generalised pustular psoriasis | 1.145 |
| 35 | Pemphigus | 1.116 |
| 285 | Fanconi anemia | 1.036 |
| 228 | Bronchiolitis obliterans | 1.017 |
| 41 | Giant cell arteritis | 1.017 |
| 137 | Focal cortical dysplasia | 1.000 |
| 192 | Cockayne syndrome | 1.000 |
| 277 | Lymphangiomatosis | 1.000 |
| 281 | Klippel-Trenaunay-Weber syndrome | 1.000 |